Quantitative hepatitis B surface antigen (qHBsAg) and quantitative hepatitis B e antigen (qHBeAg) titers are emerging as useful tools for measuring viral loads and for predicting the virological response (VR) and serological response (SR) to pegylated interferon therapy. However, the clinical utilit
Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients
β Scribed by Wang, Chia-Chi; Tseng, Tai-Chung; Wang, Pin-Chao; Lin, Hans Hsienhong; Kao, Jia-Horng
- Book ID
- 122591092
- Publisher
- Chinese Electronic Periodical Services
- Year
- 2014
- Tongue
- English
- Weight
- 615 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0929-6646
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAgβpositive and HBeAg
This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin
This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin